Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.40+0.00 (0.00%)
Close on Nov 12, 2026Market cap $242.26MP/E –Yield –
Lifecore Biomedical statistics
82 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 1.71
- 2.60
Share statisticsIndustry
- Shares Change (QoQ)
- 0.55%
- 0.51%
- Float
- 20M
- 49M
- Shares Held by Insiders
- 46.1%
- 12.1%
- Shares Held by Institutions
- 67.1%
- 56.4%
Short sellingIndustry
- Short Interest
- 2M
- –
- Short Interest Change
- -4.49%
- -0.76%
- Short % of Float
- 8.44%
- 9.04%
- Short % of Shares Outstanding
- 4.55%
- 6.30%
- Days to Cover
- 3.52
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $8.98
- –
- 52-Week Low
- $3.63
- –
- 20-Day Moving Average
- $6.41
- –
- 50-Day Moving Average
- $5.75
- –
- 200-Day Moving Average
- $5.42
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- 0.00%
- 1.51%
- Price Change (1 Month)
- -0.31%
- -2.35%
- Price Change (3 Months)
- 35.6%
- -21.1%
- Price Change (6 Months)
- 40.7%
- -22.6%
- Price Change (YTD)
- -21.8%
- -22.6%
- Price Change (1 Year)
- -17.3%
- -20.7%
- Price Change (3 Years)
- -10.4%
- -27.4%
- Price Change (5 Years)
- -32.7%
- -77.3%
- Price Change (10 Years)
- -55.6%
- -62.7%
- Average Volume (10 Days)
- 464,557
- –
- Average Volume (20 Days)
- 452,377
- –
- Average Volume (90 Days)
- 331,620
- –
- Relative Volume
- 0.33
- 0.79
- Relative Strength Index (14)
- 62.6
- 44.7
- Volatility (1 Year)
- 80.0%
- 80.4%
- Beta (5 Years)
- 1.04
- 1.07
MarginsIndustry
- Pretax Margin
- -30.0%
- -11.8%
- EBITDA Margin
- -7.15%
- -27.7%
- FCF Margin
- -10.6%
- -9.20%
Returns on capitalIndustry
- Return on Assets (ROA)
- -17.0%
- -40.6%
- Return on Capital Employed (ROCE)
- -8.36%
- -38.0%
Financial positionIndustry
- Current Ratio
- 3.84
- 3.30
- Quick Ratio
- 1.05
- 2.42
- Interest Coverage
- -0.78
- -6.35
GrowthIndustry
- Revenue Growth (3Y CAGR)
- 5.02%
- 2.25%
- Revenue Growth (5Y CAGR)
- -4.24%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.56
- 0.40
- Inventory Turnover
- 3.20
- 2.73
- Revenue Per Employee
- $337.35K
- $429.29K
- Profits Per Employee
- -$101.35K
- -$683.67K
- Employee Count
- 382
- 75
- WACC
- 10.2%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$38.67M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $22.06M
- $17.46M
- Net Cash Per Share
- $0.58
- $0.72
- Equity (Book Value)
- -$73.40M
- $53.27M
- Book Value Per Share
- -$1.94
- $1.50
- Tangible Book Value
- -$87.29M
- $26.82M
- Working Capital
- $62.64M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- -$13.42M
- -$944.00K
- FCF Per Share
- -$0.36
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -16.0%
- -20.8%
- FCF Yield
- -5.62%
- -9.58%
- Buyback Yield
- -9.84%
- -0.73%
- Shareholder Yield
- -9.84%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $22.17M
- $2.93M
- Income Tax
- $43.00K
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- -0.52
- 0.30
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | LFCR | S&P 500 | Difference | LFCR per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -0.6% | -2.7% | +2.1 pts | ||
| 3 months | +34.2% | -1.7% | +35.9 pts | ||
| Year to date | -21.8% | +11.9% | −33.7 pts | ||
| 1 year | -22.1% | +12.0% | −34.1 pts | ||
| 3 years | -8.6% | +78.2% | −86.7 pts | -2.9% | +21.2% |
| 5 years | -32.7% | +73.2% | −105.9 pts | -7.6% | +11.6% |
| 10 years | -55.6% | +309.6% | −365.2 pts | -7.8% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
2M LFCR shares were sold short on Oct 30, 2026, down 4.5% from the previous report, or 8.44% of the shares available to trade. At recent volumes it would take 3.5 days to buy them back. Over the last 20 sessions, 22.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 1,722,308 | -4.5% | 489,149 | 3.5 |
| Oct 15, 2026 | 1,803,186 | -27.2% | 652,062 | 2.8 |
| Sep 30, 2026 | 2,476,291 | -7.2% | 605,555 | 4.1 |
| Sep 15, 2026 | 2,669,844 | +10.2% | 167,495 | 15.9 |
| Aug 31, 2026 | 2,422,656 | +0.3% | 104,477 | 23.2 |
| Aug 14, 2026 | 2,415,596 | -7.3% | 139,166 | 17.4 |
| Jul 31, 2026 | 2,605,115 | +5.0% | 142,467 | 18.3 |
| Jul 15, 2026 | 2,480,304 | +4.0% | 168,844 | 14.7 |
| Jun 30, 2026 | 2,384,547 | +0.4% | 304,006 | 7.8 |
| Jun 15, 2026 | 2,374,323 | +0.8% | 193,082 | 12.3 |
| May 29, 2026 | 2,354,514 | -8.2% | 184,760 | 12.7 |
| May 15, 2026 | 2,563,701 | -5.1% | 190,937 | 13.4 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?